Section I.7 of Annex I to Regulation (EU) 2018/782 further provides that the European Medicines Agency (‘the Agency’) is to assess chemical-unlike biological substances in order to determine whether a full MRL evaluation is required and whether a ‘no MRL required’ classification according to Article 14(2), point (c), of Regulation (EC) No 470/2009 is appropriate.
Recital 5, Regulation (EU) 2026/1806
In forcesince 24 Jul 2026